JAMA Health Forum
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 5, 2022
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2461?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080522
About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.
About The Study: In this study of 482,000 children and adolescents, no association was found between state laws limiting dose or duration, or both, in opioid prescriptions and the receipt of opioid prescriptions among children and adolescents. Alternative strategies, such as opioid prescribing guidelines tailored to youths, are needed.
Authors: Elizabeth Stone, M.S.P.H., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.